Prednisone for drug-induced liver injury
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether the steroid prednisone can safely and effectively help people whose liver has been damaged by a medication and hasn't started to improve after stopping that drug. If you have moderate to severe liver injury from a medicine and your liver enzymes are still high, this might be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- Your liver injury must have been caused by a medication (diagnosed by a specialist).
- Your liver injury must be moderate to severe (liver enzymes at least 5 times normal and bilirubin high).
- Your liver tests did not improve significantly within 5-10 days after stopping the medication.
- You cannot have taken immune checkpoint inhibitors, have active infections, liver failure, certain viruses (hepatitis B/C, HIV), or be on steroids or immunosuppressants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.
This trial tests whether prednisone (an anti-inflammatory steroid) can help protect the liver in people with hepatocellular carcinoma who are getting stereotactic body radiation therapy. It may reduce liver stress from radiation and help you tolerate treatment safely.
This trial tests whether using low-dose steroids can safely manage liver inflammation caused by immunotherapy. It may help patients who have moderate liver problems from their cancer treatment but haven't yet started high-dose steroids.
This trial tests whether a short course of steroids (anti-inflammatory medication) can help people with severe alcohol-associated hepatitis. It aims to see if this treatment improves liver function and survival.
This trial tests whether plasmapheresis (a blood-cleaning procedure) can help people with severe drug-induced liver injury who also have a chronic liver condition. If you qualify, you would receive this treatment to try to reduce liver damage and improve recovery.
This trial builds a prediction model to identify drug-related liver injury (DILI) by looking at your blood test patterns, timing, and expert diagnosis. It may help improve how doctors recognize this condition earlier and more accurately.
Hear when a new Hepatotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.